Study
Vitamin D Supplementation May Reduce Colds in Adults Over 45
Taking vitamin D supplements may lower the risk of catching a cold in adults aged 45 to 74.
Summary
In plain language
Researchers studied the effects of vitamin D supplements on the common cold in healthy Japanese adults aged 45 to 74. The study found that taking a specific form of vitamin D, known as 25-hydroxyvitamin D, helped reduce the incidence of upper respiratory tract infections, like the common cold, over a 16-week period. This is significant because the common cold can be a frequent and uncomfortable issue for many people. By potentially lowering the risk of colds, vitamin D supplementation could help improve quality of life for seniors. It's a simple step that could make a difference, especially during the colder months when colds are more common.
Details
Use the full description to understand the study design, methods, and the limits of the findings.
This study was a randomized, double-blind, placebo-controlled trial involving 252 healthy Japanese adults aged 45 to 74. Participants took either a vitamin D supplement or a placebo for 16 weeks.
Researchers found those taking the vitamin D supplement had fewer colds compared to those taking the placebo.
The study focused on a specific form of vitamin D, 25-hydroxyvitamin D, which is shown to support immune function.
While promising, results are based on a specific population, and more research is needed across different groups.
For practical steps, consider discussing vitamin D supplements with your healthcare provider to see if they might benefit you.
Full Study
Open the original publication for the complete methods, outcomes, and source material.
Vitamin D Supplementation May Reduce Colds in Adults Over 45
Published October 2026
Opens at the publisher · external site · may require institutional access
Research Quality Score
Scored October 22, 2026 using rubric mq-1.8_2026-07-06.
Assessment
The study scored well in design and bias control due to its randomized, double-blind, placebo-controlled nature. Transparency was high with pre-registration and detailed reporting. However, statistical integrity was limited by power and multiplicity gaps. Conflicts of interest were significant due to industry funding and involvement. The study was relevant to the target population but lacked replication and journal quality information.
Category Breakdown
| Category | Score | Rating |
|---|---|---|
| Study design | 10.0/10 | |
| Bias control | 10.0/10 | |
| Statistical methods | 5.0/10 | |
| Reporting completeness | 10.0/10 | |
| Conflicts & funding | 5.0/10 | |
| Replication | 0.0/10 | |
| Relevance to chosen population | 10.0/10 | |
| Journal Reliability | 5.0/10 |
Additional Notes
The study investigates the effect of 25-hydroxyvitamin D3 supplementation on upper respiratory tract infections in adults aged 45-74. It found no significant reduction in infection incidence but suggested improvements in symptom severity and quality of life.
Assessed on the study's full text across 8 quality dimensions; conflict-of-interest disclosures were reviewed.
Conditions This Research Covers
These condition pages help connect the paper back to the real-world health concerns it addresses.
Treatments Evaluated in This Research
Review the interventions studied here and compare them against the broader treatment library.
Take the next step
Build a personalized plan using research-backed studies, conditions, and treatments.